GlassScriptPhysician profile
Joseph T Stubbs
NPI 1578592135
$12,859.27
in general payments reported to CMS, 2019-2025
11 companies · $7,550 in 2025
The $7,550 reported for 2025 was more than what 93% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $915 · 2020: $2,197 · 2021: $947 · 2022: $550 · 2023: $411 · 2024: $290 · 2025: $7,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Food and Beverage: $1,141 · Travel and Lodging: $1,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Food and Beverage | $1,140.74 |
| Travel and Lodging | $1,109.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,237.20 | 2019-2025 | |
| Medtronic USA, INC. | $2,029.73 | 2020 | |
| Boston Scientific Corporation | $1,763.59 | 2019-2025 | Axonics, Upsylon |
| Medtronic, INC. | $1,414.93 | 2021-2025 | Interstim, Altaviva |
| Axonics, INC. | $1,223.06 | 2020-2024 | Axonics |
| Caldera Medical, INC | $61.08 | 2022 | |
| Allergan, INC. | $32.36 | 2021-2022 | |
| Novo Nordisk INC | $28.56 | 2021 | |
| Sumitomo Pharma America, INC. | $24.31 | 2025 | Gemtesa |
| Nestle Healthcare Nutrition INC. | $23.43 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.02 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Stubbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.